Related Experiment Video
Updated: Jul 15, 2026
08:58
Procedures of Laboratory Fumigation for Pest Control with Nitric Oxide Gas
Published on: November 24, 2017
Nitric oxide as a clinical guide for asthma management
1Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. robin.taylor@stonebow.otago.ac.nz
The Journal of Allergy and Clinical Immunology
|February 8, 2006
Summary
Exhaled nitric oxide (F(E)NO) measurements help manage asthma by identifying eosinophilic airway inflammation. This guides inhaled corticosteroid (ICS) therapy and informs treatment decisions for difficult asthma cases.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Background:
- Asthma is a complex disease with varied inflammation types.
- Exhaled nitric oxide (F(E)NO) is a specific marker for eosinophilic airway inflammation.
- Eosinophilic inflammation often correlates with steroid responsiveness.
Purpose of the Study:
- To evaluate the utility of F(E)NO measurements in guiding asthma management.
- To determine the role of F(E)NO in predicting response to inhaled corticosteroids (ICS).
- To assess the prognostic significance of F(E)NO levels during ICS withdrawal.
Main Methods:
- Utilized F(E)NO measurements as a surrogate marker for airway inflammation.
- Correlated F(E)NO levels with ICS therapy effectiveness and withdrawal.
- Analyzed F(E)NO in the context of severe or difficult-to-manage asthma.
Main Results:
- High F(E)NO levels predict positive response to ICS therapy.
- Both high and low F(E)NO levels are prognostically significant for ICS withdrawal.
- Repeated F(E)NO measurements enhance cost-effectiveness of ICS therapy.
- F(E)NO aids in including or excluding active eosinophilic inflammation in symptomatic patients.
Conclusions:
- F(E)NO measurements are valuable tools for managing severe or difficult asthma.
- F(E)NO provides crucial information for clinical decision-making regarding eosinophilic inflammation.
- Further research is needed to establish definitive reference values and interpretation cut-points for F(E)NO.
More Related Videos
05:46A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...